Orthonika is developing a Total Meniscus Replacement, an entirely anatomical implant engineered with a unique fiber-reinforced structure embedded in a proprietary polymer to replicate the natural meniscus's biomechanical properties. This solution addresses the limitations of current treatments for meniscus injuries, which often lead to osteoarthritis and inadequate joint function.
Funding
$1.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Meniscus injuries often lead to osteoarthritis and inadequate joint function due to the limitations of current treatment options. Partial meniscectomy fails to restore full joint biomechanics, while partial replacement is only suitable when the meniscal rim is intact. Allograft transplantation faces challenges including donor availability, risk of infection, sizing issues, and high associated costs.
Solution
Orthonika is developing a Total Meniscus Replacement, an entirely anatomical implant designed to replicate the natural meniscus's biomechanical properties. The implant features a unique fiber-reinforced structure embedded in a proprietary polymer. This innovative structure aims to restore the structure-function relationship of the natural tissue, addressing the limitations of existing treatments and preventing the progression to osteoarthritis. The Total Meniscus Replacement is currently in the pre-clinical development stage.
Target Audience
The primary target audience includes patients with meniscus injuries and orthopaedic surgeons seeking improved treatment options to prevent osteoarthritis and restore knee function.
Features
- Entirely anatomical replacement for the meniscus of the knee.
- Engineered with a unique fiber-reinforced structure.
- Proprietary polymer material designed to replicate natural tissue properties.
- Aims to restore full joint biomechanics.